Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8822532 | European Journal of Radiology | 2018 | 8 Pages |
Abstract
There are significant differences in the degree of abdominal myosteatosis between subjects with T2DM, prediabetes and healthy controls, that may be confounded by VAT. However, abdominal myosteatosis by MRI might serve as a cardiometabolic imaging-biomarker, specifically in the setting of impaired glucose metabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Lena S. Kiefer, Jana Fabian, Susanne Rospleszcz, Roberto Lorbeer, Jürgen Machann, Corinna Storz, Mareen S. Kraus, Christopher L. Schlett, Frank Roemer, Elke Wintermeyer, Wolfgang Rathmann, Konstantin Nikolaou, Annette Peters, Fabian Bamberg,